Professor Greg Shaw
BSc, MBBS, MD, FRCS(Urol)
Consultant Urologist, London
How can I help you?
Disease of the genitals or urinary tract can cause a variety of symptoms including problems passing urine (painful urination, discoloured urine, slow urination, frequent urination or incontinence), pelvic pain, urinary infections, testis swellings, problems with sexual function such as weak erections or premature ejaculation. If you have blood in your urine this requires urgent investigation in order to rule out a dangerous cause. A raised PSA can be identified in the absence of symptoms and requires careful assessment to exclude prostate cancer. I am expert in investigating the cause of these problems so that they can be properly dealt with once the cause is known.
I also have a particular interest in investigating, diagnosing and treating patients with prostate cancer. An outpatient consultation will involve full consideration of your personal concerns and priorities resulting in planning of the most appropriate course of action for you with state of the art diagnostics and appropriate treatment where it is required.
I take pride in establishing positive therapeutic relationships with my patients and their families.
Patients with prostate cancer and other urological problems will find the care they are looking for with me at my specialist urology clinic in London. I provide care for patients both in the NHS at University College London Hospitals (UCLH) and St Bartholomew's Hospital, and private patients at the Princess Grace Hospital, The Shard and The Prostate Centre.
I use a range of biopsy approaches including transperineal and MRI guided biopsies, to diagnose prostate cancer. I also perform benign prostate surgery and inguino-scrotal surgery.
I am a specialist in using robotic surgery for the treatment of prostate cancer. I perform 150 robotic prostatectomies per year, amongst the highest rate for UK urologists. I am actively involved in clinical research and is leading on the National ‘Provent’ study for men on active surveillance for prostate cancer and the NeuroSAFE PROOF study to evaluate the use of the NeuroSAFE procedure for NHS patients. Patient feedback can be viewed here at the doctify website.